Percutaneous Embolization of Varicoceles: Outcomes and Correlation of Semen Improvement with Pregnancy
Monday, 29 March 2004
BERKELEY, CA (UroToday Inc.) - Varicocele remains the most common correctable etiologic factor in the management of infertility.
read more
|
Tension-Free Vaginal Tape Proven Equally Effective in both Younger and Older Women
Monday, 29 March 2004
BERKELEY, CA (UroToday Inc.) - An estimated 35% of community dwelling elderly women suffer from urinary incontinence, with the incidence increasing with age.
read more
|
Rhabdomyosarcoma of the Bladder, Prostate or Vagina: The Role of Surgery
Thursday, 25 March 2004
BERKELEY, CA (UroToday Inc.) - Of all reported rhabdomyosarcoma (RMS), 13-20% arises within the genitourinary tract, most commonly in the bladder, prostate, vagina, uterus or paratesticular tissue.
read more
|
Genetic Syndrome Tied to Panic Disorder and Bladder Problems
Friday, 12 March 2004
NEW YORK (Reuters Health) - The seemingly disparate conditions of panic disorder, interstitial cystitis and thyroid abnormalities may be components of a hitherto unidentified genetic syndrome, researchers report in the March issues of the Archives of General Psychiatry.
read more
|
New Guidelines Issued for Chronic Pelvic Pain
Tuesday, 09 March 2004
NEW YORK (Reuters Health) - The American College of Obstetricians and Gynecologists has issued a new practice bulletin for chronic pelvic pain, a condition that can be difficult to diagnose and treat.
read more
|
Blood Marker Is A Powerful Predictor of Nontraumatic Fracture
Thursday, 04 March 2004
NEW YORK (Reuters Health) - A low serum concentration of the ligand for receptor activator of NFkB (RANKL) is a significant and independent predictor for nontraumatic fracture in healthy adults, research indicates.
read more
|
Pfizer Not Moving Ahead with Viagra for Women
Tuesday, 02 March 2004
NEW YORK (Reuters) - Pfizer Inc. on Friday said it was unable to prove that its impotence drug Viagra was effective in treating women, and it would not seek regulatory approval for it as a treatment for female sexual arousal disorder.
read more
|
Older Women No Less Likely to Have Sexual Healthcare Needs
Monday, 01 March 2004
NEW YORK (Reuters Health) - Compared with younger women, women over age 65 have as many sexual concerns and as much interest in discussing these issues with their physicians, according to a new study.
read more
|
Investing in Sexual Health Would Save 1.5 Million Lives a Year
Tuesday, 03 February 2004
LONDON (Agence de Presse Medicale for Reuters Health) - Millions of lives could be saved by increased investment in contraceptive services, according to a report released on Tuesday by the United Nations Population Fund and the Alan Guttmacher Institute.
read more
|
Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic Procedures
Thursday, 08 January 2004
BERKELEY, CA (UroToday Inc.) - Postmenopausal women taking unopposed estrogen have historically been thought to be at risk for developing gynecologic malignancies.
read more
|
Association of Funding and Conclusions in Randomized Drug Trials
Thursday, 08 January 2004
BERKELEY, CA (UroToday Inc.) - Past studies have suggested that industry sponsored trials tend to draw conclusions supporting the use of the industry drug.
read more
|
Risk-Benefit Ratio Speaks Against Estrogen Plus Progestin Therapy to Decrease Fracture Risk or Improve Bone Mineral Density
Thursday, 08 January 2004
BERKELEY, CA (UroToday Inc.) - The Women's Health Initiative (WHI) trial, completed in July 2002, was designed to determine the effects of estrogen-plus-progestin on a number of chronic diseases including the risk of osteoporotic fractures and bone mineral density.
read more
|
Hormone Replacement Drug Use Tumbles, Study Says
Tuesday, 06 January 2004
CHICAGO (Reuters) - Studies showing that hormone replacement therapy raises the risk of heart disease, cancer and blood clots have knocked U.S. prescriptions for the drugs back to where they were nine years ago, a report said on Tuesday.
read more
|
Long-term Results of Sacrohysteropexy for Uterovaginal Prolapse 'Excellent'
Wednesday, 31 December 2003
NEW YORK (Reuters Health) - Abdominal sacrohysteropexy is safe and effective for the treatment of young women with uterovaginal prolapse, according to a retrospective study with an average of 8 years follow-up.
read more
|
Pelvic Floor Exercises May Not Improve Postpartum Incontinence
Monday, 08 December 2003
NEW YORK (Reuters Health) - US researchers have identified several factors that are associated with an increased risk of urinary incontinence in the 12-month postpartum period, according to a new report.
read more
|
Female Urology 
